| Sara Moore, | |
|
2900 Main St Ste 1d, Stratford, CT 06614-4946 | |
| (203) 378-0092 | |
| Not Available |
| Full Name | Sara Moore |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2900 Main St Ste 1d, Stratford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558145532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Moore, 1931 Black Rock Tpke, Fairfield, CT 06825-3506 Ph: (203) 384-8681 | Sara Moore, 2900 Main St Ste 1d, Stratford, CT 06614-4946 Ph: (203) 378-0092 |
News Archive
The Radiology journal released new data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer that shows Positron Emission Mammography (PEM) may reduce unnecessary breast biopsies. The study found that PEM was significantly more precise at identifying benign and cancerous lesions, in what scientists call "Positive Predictive Value" or "PPV," therefore reducing the number of unnecessary biopsies.
Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2009.
Columbia Laboratories, Inc. today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock.
Severe periodontal disease causes tooth loss and affects a certain group of people that appear to exhibit increased susceptibility to periodontal destruction, according to a study that appeared in the November Journal of Periodontology.
A new study, conducted by researchers from the Institut Pasteur in Paris and the Centre for Genomic Regulation (CRG) in Barcelona, have revealed that Leishmania adaptation is a consequence of reversible and frequent chromosomal amplifications.
› Verified 9 days ago
Communicate Anew Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Cedar St, Stratford, CT 06615 Phone: 203-522-1708 | |
Mrs. Carla Y. Loxsom, M. ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 304 Housatonic Ave, Stratford, CT 06615 Phone: 203-375-2577 | |
Kaelyn Bonaventura, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Old Coach Ln, Stratford, CT 06614 Phone: 203-522-0646 | |
Ms. Meredith D'agostino, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 380 Chapel St, Stratford, CT 06614 Phone: 203-882-1838 | |
Lauren Finnegan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 175 Nutmeg Ln, Stratford, CT 06614 Phone: 203-394-1496 | |
Elizabeth Benz, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Main St, Suite 1d, Stratford, CT 06614 Phone: 203-378-0092 Fax: 203-375-4540 | |
Adriana Chamberlain, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Main St, Suite 1d, Stratford, CT 06614 Phone: 203-378-0092 Fax: 203-375-4540 |